343 related articles for article (PubMed ID: 28508290)
1. CRISPR/Cas9-mediated somatic and germline gene correction to restore hemostasis in hemophilia B mice.
Huai C; Jia C; Sun R; Xu P; Min T; Wang Q; Zheng C; Chen H; Lu D
Hum Genet; 2017 Jul; 136(7):875-883. PubMed ID: 28508290
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse.
Guan Y; Ma Y; Li Q; Sun Z; Ma L; Wu L; Wang L; Zeng L; Shao Y; Chen Y; Ma N; Lu W; Hu K; Han H; Yu Y; Huang Y; Liu M; Li D
EMBO Mol Med; 2016 May; 8(5):477-88. PubMed ID: 26964564
[TBL] [Abstract][Full Text] [Related]
3. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs.
Morishige S; Mizuno S; Ozawa H; Nakamura T; Mazahery A; Nomura K; Seki R; Mouri F; Osaki K; Yamamura K; Okamura T; Nagafuji K
Int J Hematol; 2020 Feb; 111(2):225-233. PubMed ID: 31664646
[TBL] [Abstract][Full Text] [Related]
5. Paired CRISPR/Cas9 Nickases Mediate Efficient Site-Specific Integration of
Wang Y; Zhao J; Duan N; Liu W; Zhang Y; Zhou M; Hu Z; Feng M; Liu X; Wu L; Li Z; Liang D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301136
[TBL] [Abstract][Full Text] [Related]
6. Generation of an mESC model with a human hemophilia B nonsense mutation via CRISPR/Cas9 technology.
Ma Y; Sun W; Zhao L; Yao M; Wu C; Su P; Yang L; Wang G
Stem Cell Res Ther; 2022 Jul; 13(1):353. PubMed ID: 35883203
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
[TBL] [Abstract][Full Text] [Related]
8. Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9.
Stephens CJ; Lauron EJ; Kashentseva E; Lu ZH; Yokoyama WM; Curiel DT
J Control Release; 2019 Mar; 298():128-141. PubMed ID: 30771412
[TBL] [Abstract][Full Text] [Related]
9. Designer nuclease-mediated gene correction via homology-directed repair in an in vitro model of canine hemophilia B.
Bergmann T; Ehrke-Schulz E; Gao J; Schiwon M; Schildgen V; David S; Schildgen O; Ehrhardt A
J Gene Med; 2018 May; 20(5):e3020. PubMed ID: 29608237
[TBL] [Abstract][Full Text] [Related]
10. [A quick and efficient method to generate hemophilia B mouse models by the CRISPR/Cas system].
Wang QH; Huai C; Sun R; Zhuang H; Chen HY; Fei J; Lu DR
Yi Chuan; 2015 Nov; 37(11):1143-8. PubMed ID: 26582528
[TBL] [Abstract][Full Text] [Related]
11. Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9.
Singh K; Evens H; Nair N; Rincón MY; Sarcar S; Samara-Kuko E; Chuah MK; VandenDriessche T
Mol Ther; 2018 May; 26(5):1241-1254. PubMed ID: 29599079
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-mediated correction of human genetic disease.
Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX-knockout mice.
Wang L; Yang Y; Breton CA; White J; Zhang J; Che Y; Saveliev A; McMenamin D; He Z; Latshaw C; Li M; Wilson JM
Blood; 2019 Jun; 133(26):2745-2752. PubMed ID: 30975639
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Mediated In Situ Introduction or Integration of
Tang Q; Hu Z; Zhao J; Zhou T; Tang S; Wang P; Xiao R; Chen Y; Wu L; Zhou M; Liang D
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240366
[TBL] [Abstract][Full Text] [Related]
15. Inherent hepatocytic heterogeneity determines expression and retention of edited
Wang Q; Zhang L; Zhang GW; Mao JH; Xi XD; Jiang L; Lv G; Lu J; Shen Y; Chen Z; Zhu J; Chen SJ
Proc Natl Acad Sci U S A; 2021 Oct; 118(42):. PubMed ID: 34649996
[TBL] [Abstract][Full Text] [Related]
16. Long-term correction of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integration.
Chen X; Niu X; Liu Y; Zheng R; Yang L; Lu J; Yin S; Wei Y; Pan J; Sayed A; Ma X; Liu M; Jing F; Liu M; Hu J; Wang L; Li D
J Genet Genomics; 2022 Dec; 49(12):1114-1126. PubMed ID: 35691554
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs.
Chen J; An B; Yu B; Peng X; Yuan H; Yang Q; Chen X; Yu T; Wang L; Zhang X; Wang H; Zou X; Pang D; Ouyang H; Tang X
Haematologica; 2021 Mar; 106(3):829-837. PubMed ID: 31974191
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna.
Kumagai H; Nakanishi T; Matsuura T; Kato Y; Watanabe H
PLoS One; 2017; 12(10):e0186112. PubMed ID: 29045453
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Editing of the Adult Mouse Liver Using CRISPR/Cas9 and Hydrodynamic Tail Vein Injection.
Niola F; Dagnæs-Hansen F; Frödin M
Methods Mol Biol; 2019; 1961():329-341. PubMed ID: 30912055
[TBL] [Abstract][Full Text] [Related]
20. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
